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INTRO
• Peripheral myoclonus is a rare 
post-amputation complication 
characterized by sudden, brief 
and sometimes repetitive 
muscle contractions.
• BoNT-A prevents the release of 
the neurotransmitter 
acetylcholine at the axon 
ending of the neuromuscular 
junction and blocks contraction.
• No standard treatment exists.
METHODS
• A 57-year-old man with below-
knee amputation due to 
infected post-traumatic 
aneurysm of the popliteal 
artery developed myoclonus in 
his stump.
• Reported injection protocols, 
lasting treatment time, 
donning time-period, and 
satisfaction of the patient.
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RESULTS
• Discomfort improved after 
injections and led to a 
longer donning period.
• Multiple attempts were 
necessary before finding 





• BoNT-A is not officially 
indicated for peripheral 
myoclonus treatment, but 
was effective in this case.
• After failure of conservative 
treatments, BoNT-A should 
be considered as a 
therapeutic approach.
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